We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$106M
Cap. Flow
-$30.8M
Cap. Flow %
-0.75%
Top 10 Hldgs %
25.55%
Holding
1,074
New
41
Increased
384
Reduced
253
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.8M
2
WAB icon
Wabtec
WAB
+$16.3M
3
DAL icon
Delta Air Lines
DAL
+$15.1M
4
FTV icon
Fortive
FTV
+$13.7M
5
LYB icon
LyondellBasell Industries
LYB
+$9.21M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$18.7M
2
CELG
Celgene Corp
CELG
+$18M
3
INTC icon
Intel
INTC
+$12.5M
4
CTSH icon
Cognizant
CTSH
+$12.4M
5
FTNT icon
Fortinet
FTNT
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 19.96%
2 Financials 16.17%
3 Consumer Discretionary 12.29%
4 Healthcare 10.9%
5 Industrials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROCC
1001
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$43K ﹤0.01%
+1,386
New +$51.6K
ENV
1002
DELISTED
ENVESTNET, INC.
ENV
$42K ﹤0.01%
612
– –
WVE icon
1003
Wave Life Sciences
WVE
$1.09B
$40K ﹤0.01%
1,530
+306
+25% +$8.58K
OPTU
1004
Optimum Communications Inc
OPTU
$298M
$39K ﹤0.01%
1,624
-28
-2% -$665
MYOK
1005
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$37K ﹤0.01%
728
– –
ATYR
1006
aTyr Pharma
ATYR
$47.6M
$36K ﹤0.01%
7,082
– –
KGC icon
1007
Kinross Gold
KGC
$27.4B
$35K ﹤0.01%
9,316
+1,870
+25% +$6.3K
LOVE
1008
DELISTED
LoveSac
LOVE
$35K ﹤0.01%
+1,122
New +$38.6K
XLRN
1009
DELISTED
Acceleron Pharma
XLRN
$34K ﹤0.01%
836
-6,226
-88% -$258K
PEGA icon
1010
Pegasystems
PEGA
$5.02B
$33K ﹤0.01%
924
-1,320
-59% -$47K
SNDX icon
1011
Syndax Pharmaceuticals
SNDX
$1.69B
$33K ﹤0.01%
3,584
– –
DAY
1012
DELISTED
Dayforce
DAY
$33K ﹤0.01%
660
-1,012
-61% -$51.2K
GWRE icon
1013
Guidewire Software
GWRE
$12.6B
$31K ﹤0.01%
+308
New +$31.4K
QTWO icon
1014
Q2 Holdings
QTWO
$3.8B
$31K ﹤0.01%
408
– –
SRPT icon
1015
Sarepta Therapeutics
SRPT
$1.57B
$30K ﹤0.01%
198
– –
SILK
1016
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$30K ﹤0.01%
+616
New +$26.2K
BB icon
1017
BlackBerry
BB
$4.98B
$28K ﹤0.01%
3,944
+816
+26% +$7.08K
MEOH icon
1018
Methanex
MEOH
$4.3B
$28K ﹤0.01%
646
+34
+6% +$1.71K
TWST icon
1019
Twist Bioscience
TWST
$5.7B
$27K ﹤0.01%
924
+462
+100% +$12.2K
KURA icon
1020
Kura Oncology
KURA
$800M
$26K ﹤0.01%
1,298
-1,188
-48% -$19.7K
GRUB
1021
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$26K ﹤0.01%
+165
New +$22.5K
DNTH icon
1022
Dianthus Therapeutics
DNTH
$5.84B
$25K ﹤0.01%
105
– –
MRTX
1023
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$25K ﹤0.01%
242
– –
RETA
1024
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$25K ﹤0.01%
264
+110
+71% +$9.5K
AZPN
1025
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$25K ﹤0.01%
204
-714
-78% -$87.5K
39 40
41
42 43

Similar funds

GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Elkfork Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Elkfork Partners held 1,074 positions worth $4.09B, up 2.7% from $3.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Elkfork Partners's Q2 2019 filing shows 41 new, 384 increased, 253 reduced and 27 closed positions. Its largest new stake was L3Harris: 31,108 shares worth $5.88M. The largest sale was Linde, an estimated $18.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Elkfork Partners's largest Q2 2019 buy was L3Harris: 31,108 shares worth $5.88M.
  • Elkfork Partners added most to Microsoft in Q2 2019, an estimated $17.8M increase.
  • Elkfork Partners's biggest Q2 2019 reduction was Linde, cutting an estimated $18.7M.
  • Elkfork Partners fully exited Burlington in Q2 2019, selling an estimated $1.99M.
  • Elkfork Partners's ten largest holdings make up 26% of its $4.09B portfolio in Q2 2019.
  • Elkfork Partners opened 41 new positions and closed 27 in Q2 2019.
  • Elkfork Partners's portfolio value rose 2.7% quarter-over-quarter to $4.09B.

Based on Elkfork Partners's 13F filing for Q2 2019, filed 13 Aug 2019.